ArticlemBio2024
The ICU environment contributes to the endemicity of the "
Open access · goldAbstract read
In one paragraph
Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 33 citations in OpenAlex.
- Comparative analyses of the Serratia marcescens complex reveal variations in their pathogenicity against a fruit pest.Pest management science · 2026Article
- Serratia Bacteraemia in the North Denmark Region: A Population-Based Study (2010-2024).APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026Article
- Identifying and quantifying ESKAPEE pathogens in and around sinks in high burden hospitals.The Journal of hospital infection · 2026Observational
- The current discordance on Serratia spp. taxonomical diagnosis using proteomics or genomic tools.BMC microbiology · 2026Article
- Review
- From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026Review
- Contact-mediated bacterial transmission and infection risk dynamics in a newly opened hospital ward.BMC microbiology · 2026Article
- Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026Review
- Identifying and quantifying ESKAPEE pathogens in and around sinks in high burden hospitals.medRxiv : the preprint server for health sciences · 2026Article
- Variable chlorhexidine MICs acrossAntimicrobial agents and chemotherapy · 2026Article
- In vivo evolution of resistance to novel β-lactam/β-lactamase inhibitor combinations through overproduction of the horizontally acquired extended-spectrum AmpC β-lactamase FOX-14 and porin disruption in Serratia marcescens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Capnocytophaga canimorsus: meningitis and Waterhouse-Friderichsen syndrome in an immunocompetent patient.Forensic science, medicine, and pathology · 2026Article
- The Fires of Isengard Have Spread:Pathogens (Basel, Switzerland) · 2026Article
- Clinical and Genomic Characterization of Serratia Bloodstream Infections.CMI communications · 2025Article
- Article
- Article
- Therapeutic approach in the critically ill patient with suspected multidrug resistance.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025Review
- Understanding Serratia bockelmannii transmission during a neonatal intensive care unit outbreak: a combined genotyping and case-control study.Antimicrobial resistance and infection control · 2025Article
- Molecular Epidemiology of Clinical Infections Caused by Serratia marcescens Complex in a Tertiary Care Hospital System: Insights From Whole-Genome Sequencing.The Journal of infectious diseases · 2025Article
- Transmission dynamics of ST346 carbapenem-resistantiScience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 4 institutions in 4 countries.
Sonia Aracil-GisbertMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-1174-7228
Miguel D Fernández-De-BobadillaMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-4594-2427
Natalia Guerra-PintoMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0009-0006-4230-4450
Silvia Serrano-CallejaMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
Ana Elena Pérez-CobasMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-3995-5571
Cruz SorianoIntensive Medicine, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-5906-5365
Raúl de PabloIntensive Medicine, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
Val F LanzaBiomedical Research Center Network of Infectious Diseases (CIBERINFEC), Madrid, Spain.ORCID 0000-0003-0870-9500
Blanca Pérez-VisoMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-0693-597X
Sandra ReutersMember of the ESCMID Study Group for Epidemiological Markers (ESGEM), Basel, Switzerland.ORCID 0000-0003-1672-5789
Henrik HasmanMember of the ESCMID Study Group for Epidemiological Markers (ESGEM), Basel, Switzerland.ORCID 0000-0001-6314-2709
Rafael CantónMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0003-1675-3173
Fernando BaqueroMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-7930-3033
Teresa M CoqueMicrobiology, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.ORCID 0000-0002-8228-3491
Instituto Cajal · ESUniversidad de Alcalá · ESStatens Serum Institut · DKUniversity of Freiburg · DE
Funding
Biomedical Research Center Network of Infectious Diseases (CIBERINFEC) CB21/13/00084European Commission (EC) MISTAR AC21_2/00041Fundacion Francisco Soria Melguizo CC23140547MEC | Instituto de Salud Carlos III (ISCIII) PI18/1942, PI21/02027
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cross InfectionIntensive Care UnitsSerratia InfectionsSerratia marcescensAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDisease OutbreaksGenome, BacterialHospitalsHumansMicrobial Sensitivity TestsPhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesAmpChospital environmentIncLplasmidSerratiaSerratia marcescensSerratia nevei“source-sink” dynamicsVIM-1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.